Ohio State Navbar


Diabetes Dialogue Series 2015

The Diabetes Dialogue is a series formulated to provide the latest breakthroughs in diabetes research and clinical practice to the medical community. In particular, the meeting will focus on non-pharmacological intervention in the management of obesity and diabetes.While there is no doubt that medication treatment is effective in most patients, it is also clear that it is extremely difficult to achieve the American Diabetes Association Recommended AIC goal of less that 7% in most patients. Alternative approaches are needed to complement the medication treatment of patients with diabetes.

The Ohio State University Medical Center, Center for Continuing Medical Education (CCME) is accredited by the Accreditation Council for Continuing Medical Education (ACCME®) to provide continuing medical education for physicians. The Ohio State University Medical Center, Center for Continuing Medical Education designates this educational activity for a maximum of 1.5 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

2015 diabetes Dialogue: Emerging Influence of obesity on Type 1 and Type 2 Diabetes

Obesity 2015; March 19, 2015

1. Discuss the epidemic of obesity and its complications
2. Outline mechanisms of inflammation in obesity
3. Review treatment strategies

Diabetes and Pregnancy; June 11, 2015

1. Identify preconception glycemic goals for women with preexisting diabetes planning pregnancy.
2. Recognize the reasons for preconception planning for women with diabetes.
3. Explain treatment options (oral agents, insulins, and diet changes) for women with diabetes during pregnancy.
4. Recognize the importance of screening for gestational diabetes and for screening women with a history of gestational diabetes for diabetes in the immediate postpartum period.

For registration, click here.

Diabetes Care in the Elderly; September 10, 2015

  1. Review the magnitude of the diabetes epidemic in the elderly.
  2. Identify treatment goals for elderly patients with Type 1 and Type 2 Diabetes Mellitus.
  3. Assess the risk of diabetic complications and how to weigh this risk against the adverse effects of hypoglycemia.
  4. Describe the treatment options available for elderly patients with Type 2 diabetes

For registration, click here.

NASH; December 10, 2015

For information, click here.